Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy (EPZSwitch)

This study is currently recruiting participants.
Verified May 2012 by Therapeutic Concepts
Sponsor:
Information provided by (Responsible Party):
Therapeutic Concepts
ClinicalTrials.gov Identifier:
NCT01608269
First received: May 25, 2012
Last updated: May 29, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)